Skip to main content

Dyspareunia(painful sex) leads to Low Sexual Desire in Women: What Are the Options?

Vulvovaginal atrophy, along with vaginal dryness and other symptoms caused by the loss of estrogen associated with postmenopausal status, are major contributors to dyspareunia. Fortunately, a range of effective treatments are available. For women who want to avoid systemic hormone therapy, intravaginal estrogens come in several formulations. "There is also a new nonestrogen vaginal product called prasterone (Intrarosa®)—a good solution for women who don't want estrogen.
Prasterone is a synthetic dehydroepiandrosterone, a hormone precursor that is converted peripherally to androgens, which exert local effects on the vaginal mucosa. Prasterone has been shown to improve symptoms, including vaginal atrophy, dyspareunia, burning, itching, and dryness, compared with placebo.
Another alternative to hormone therapy is ospemifene (Osphena®), approved in 2013 for treatment of moderate to severe dyspareunia associated with vulvar and vaginal atrophy of menopause. Ospemifene is an oral selective estrogen receptor modulator that acts on the vaginal epithelium to address painful sex associated with genitourinary syndrome of menopause. In phase 3 studies, ospemifene demonstrated efficacy in vaginal dryness and dyspareunia by regenerating vaginal cells, improving lubrication, and reducing pain during sexual intercourse. Symptoms improved in the first 4 weeks of use, and lasted up to 1 year.

A nondrug option has recently joined the field. In observational studies, the pulsed CO2 laser (MonaLisa Touch [Deka; Manchester, New Hampshire]), which directly treats the vaginal tissue, was shown to increase collagen and extracellular matrix production and increase the thickness of the vaginal epithelium with the formation of new papilla.Three 5-minute treatments are given at 6-week intervals, and no anesthesia is required.

Low Sexual Desire in Women: What Are the Options? - Medscape -Jul 09, 2018.

Comments

Popular posts from this blog

How healthy is genetically modified soybean oil?

University of California-Riverside Soybean oil accounts for more than 90 percent of all the seed oil production in the United States. Genetically modified soybean oil, made from seeds of GM soybean plants, was recently introduced into the food supply on the premise that it is healthier than conventional soybean oil. But is that premise true? Just barely, say scientists. Researchers at the University of California, Riverside have tested a genetically-modified (GM) soybean oil used in restaurants and found that while it induces less obesity and insulin resistance than conventional soybean oil, its effects on diabetes and fatty liver are similar to those of conventional soybean oil.

HEALTH BENEFITS OF CHEWING RAW GARLIC

HEALTH BENEFITS OF CHEWING RAW GARLIC You might not make a lot of new friends if you chew on garlic, a plant used for centuries as both a pungent flavoring and a medicine. A member of the onion family, garlic contains a powerful sulfur compound called allicin, which also lends it a distinctive – and to many people, unpleasant – smell.Garlic not only makes food delicious, it may also have a number of health benefits. The allicin in garlic exhibits strong antioxidant activity – the ability to fight harmful free radicals in the body – which has led scientists to study its health-promoting properties. OFFERS AN ANTI-INFLAMMATORY EFFECT  If you suffer from an inflammatory condition, it may help to consume raw garlic. A study published in "Food and Chemical Toxicology" in August 2013 found that garlic had an anti-inflammatory effect, with raw garlic exhibiting a stronger effect than garlic that had been  heated. The levels of a compound called allicin were great...

Babies are born to dance, new research shows

University of York The findings, based on the study of infants aged between five months and two years old, suggest that babies may be born with a predisposition to move rhythmically in response to music. The research was conducted by Dr Marcel Zentner, from the University of York's Department of Psychology, and Dr Tuomas Eerola, from the Finnish Centre of Excellence in Interdisciplinary Music Research at the University of Jyvaskyla.